Ticker Details
Sight Sciences, Inc. Common Stock
IPO Date:	July 12, 2021
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$455.03M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.31 | 3.83%
Avg Daily Range (30 D):	$0.26 | 4.33%
Avg Daily Range (90 D):	$0.20 | 3.91%

Institutional Daily Volume
Avg Daily Volume:	.21M
Avg Daily Volume (30 D):	.21M
Avg Daily Volume (90 D):	.2M

Trade Size
Avg Trade Size (Sh.):	80
Avg Trade Size (Sh.) (30 D):	65
Avg Trade Size (Sh.) (90 D):	64

Institutional Trades
Total Institutional Trades:	135
Avg Institutional Trade:	$2.26M
Avg Institutional Trade (30 D):	$.67M
Avg Institutional Trade (90 D):	$1.92M
Avg Institutional Trade Volume:	.2M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.17M
Avg Closing Trade (30 D):	$2.27M
Avg Closing Trade (90 D):	$1.11M
Avg Closing Volume:	256.07K

News

Sep 9, 2025 @ 3:39 PM UnitedHealthcare Adds Sight Sciences OMNI System T... Source: Vandana Singh

Jul 30, 2025 @ 11:00 AM Sight Sciences Announces the Results of a Cost-Uti... Source: Nathan Lighthizer Et Al.

Jul 29, 2025 @ 11:00 AM Sight Sciences Announces the Publication of the 24... Source: Sight Sciences, Inc.

Feb 10, 2025 @ 3:00 PM Dry Eye Treatment Devices Market Poised to Attain ... Source: Astute Analytica

Jul 18, 2024 @ 8:06 PM Sight Sciences to Report Second Quarter Financial ... Source: N/A

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.08	$-.24	$-.08
Diluted EPS	$-.08	$-.24	$-.08
Revenue	$23.39M	$19.7M	$20.39M
Gross Profit	$21.37M	$16.98M	$17.79M
Net Income / Loss	$-4.45M	$-12.98M	$-4.16M
Operating Income / Loss	$-3.89M	$-12.41M	$-3.67M
Cost of Revenue	$2.01M	$2.72M	$2.6M
Net Cash Flow	$-5.21M	$-7M	$-.41M
PE Ratio